Replies to post #1405 on InMed Pharmaceuticals Inc (INM)

[stockfan100]

I don't think so. IMLFF is in BioPharma business, not a MJ grower. It is not growing MJ that is already getting saturated.

IMLFF is planning to identify as many of 90 cannabinoid genes that are in cannabis, identify what diseases they can be effective on, use a little of those genes material to do mass production of meds (biosynthesis) based on that result similar to a technique that is being used to mass produce insulin these days.

No Biomed company has done this before in the cannabis field. Perhaps, that is why the VP of Investment Banking of one of the largest global drug manufacturing companies in the world has just joined the board of directors of IMLFF.

Food for thought - The VP that joined IMLFF earlier this week is already making hundreds of thousands of dollars (perhaps millions after all perks) a year. It is said (I have not read the reports about this yet) he is getting one million shares of IMLFF.

Do you think a VP in such capacity just joins another company's board of directors for money...like a little over $20,000 only? (one million shares times a little about 2 cents)

Or, it makes sense to believe that this is just the beginning of a major cooperation/merger opportunity between one of the global Biopharma giants and IMLFF? No brainer!

[lesgetrich]

Most analysts would consider this stock to be part of the MJ sector, just like they consider GW Pharmaceuticals to be in the MJ sector. That doesn't mean it's not a BioPharmaceutical company or can not also be considered part of the healthcare or pharmaceutical sectors. These classifications are somewhat arbitrary.